193 related articles for article (PubMed ID: 15041322)
1. Impact of cyclosporine on the development of immunosuppressive therapy.
Fritsche L; Dragun D; Neumayer HH; Budde K
Transplant Proc; 2004 Mar; 36(2 Suppl):130S-134S. PubMed ID: 15041322
[TBL] [Abstract][Full Text] [Related]
2. History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion.
Cantarovich M; Barkun J; Giannetti N; Cecere R; Besner JG; Tchervenkov J
Transplant Proc; 2004 Mar; 36(2 Suppl):442S-447S. PubMed ID: 15041383
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
4. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
Konstadinidou I; Boletis JN
Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
6. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
Kliem V; Fritsche L; Haller H; Suwelack B; Abendroth D; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U; Ulbricht B;
Transplant Proc; 2005 Apr; 37(3):1597-600. PubMed ID: 15866683
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitors in heart transplantation.
Keogh A
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
[TBL] [Abstract][Full Text] [Related]
9. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine.
Hoyer PF; Vester U
Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336
[TBL] [Abstract][Full Text] [Related]
10. Experience with cyclosporine in the Canary Islands.
Hernández D
Transplant Proc; 2004 Mar; 36(2 Suppl):120S-124S. PubMed ID: 15041320
[TBL] [Abstract][Full Text] [Related]
11. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring.
Sharma A; Shekhar C; Heer M; Minz M
Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of cyclosporine.
Midtvedt K
Transplant Proc; 2004 Mar; 36(2 Suppl):430S-433S. PubMed ID: 15041380
[TBL] [Abstract][Full Text] [Related]
13. Optimization of cyclosporine for liver transplantation.
Lilly LB; Grant D
Transplant Proc; 2004 Mar; 36(2 Suppl):267S-270S. PubMed ID: 15041351
[TBL] [Abstract][Full Text] [Related]
14. Neoral/cyclosporine-based immunosuppression.
Levy GA
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S37-47. PubMed ID: 10431016
[TBL] [Abstract][Full Text] [Related]
15. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
16. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
18. Future directions in immunosuppression.
Beckebaum S; Cicinnati VR; Broelsch CE
Transplant Proc; 2004 Mar; 36(2 Suppl):574S-576S. PubMed ID: 15041408
[TBL] [Abstract][Full Text] [Related]
19. A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in Canada.
Hemming AW; Cattral MS; Greig PD; Meisner J; Turcotte L; Lilly LB; Levy GA
Clin Transplant; 1998 Oct; 12(5):425-9. PubMed ID: 9787952
[TBL] [Abstract][Full Text] [Related]
20. Update on liver transplantation using cyclosporine.
Schrem H; Lück R; Becker T; Nashan B; Klempnauer J
Transplant Proc; 2004 Nov; 36(9):2525-31. PubMed ID: 15621081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
